CSL PHARMACEUTICALS (ASX:CSL)
Hi All, Here was my thought process for entering this trade. BOUGHT - LONG - AV. PRICE 199.23 - 6 AUG 18 Disclaimer: I am not a qualified financial advisor and the following should not be taken as recommendations or financial advice. FUNDAMENTAL ANALYSIS Since my style is shorter term trading I do not put too much emphasis on fundamentals. However, there are still key signals I look for. Balance Sheet/ Margin of Safety I've calculated the current ratio of CSL to be 2.86 and quick ratio to be 1.4 based on the values of their 6-month report ending December 2017. This ensures the company is able to cover its short term liabilities and will not default in the near future (whilst I am holding). Growth/ Profitability Revenue grew by 12.8% from the end of 2017 compared to the end of 2016, it is not amazing but is still better than a decrease. What caught my eye was the 35.8% growth in EPS during this same time period and with the annual year report due just around the co...